m-amino-phenylimino-imidazolidine derivatives (Boehringer)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Namem-amino-phenylimino-imidazolidine derivatives (Boehringer)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdrenergic receptor alpha-1 agonists
TargetsAdrenergic receptors alpha-1
Therapy Area/IndicationsUrinary Incontinence
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBoehringer Ingelheim International Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBoehringer Ingelheim International Gmbh
Active IndicationsN/A
Inactive IndicationsUrinary Incontinence

Other Information

ATC CodeN/A
Related LinksN/A